Skip to main content
. 2015 May 11;6(26):22985–22995. doi: 10.18632/oncotarget.3945

Figure 1. Patient survival curves according to tumor size.

Figure 1

A. The entire cohort, P < 0.001. B. The estrogen receptor (ER)-positive and progesterone receptor (PR)-positive group, P < 0.001. C. The ER-negative and PR-negative group, P < 0.001.